Literature DB >> 22914954

ALDH as a marker for enriching tumorigenic human colonic stem cells.

Anitha Shenoy1, Elizabeth Butterworth, Emina H Huang.   

Abstract

Aldehyde dehydrogenase (ALDH) can be used as a marker to isolate, propagate, and track normal and cancerous human colon stem cells. To determine their tumorigenic potential, tissues obtained from proximal (normal counterpart) and distal (cancerous) colon of colon cancer patients are implanted into NOD-SCID mice. In parallel, ALDH(high) and ALDH(low) cells are isolated via Florescence Associated Cell Sorting (FACS) after the dissociation of distal and proximal colon tissues into a single-cell suspension. Flow cytometry for ALDH(high) and ALDH(low) cells is possible with the ALDEFLUOR assay. Following cell sorting, ALDH-enriched cells are tested for their tumorigenic potential in vivo as xenografts. Owing to cancer stem cell properties, ALDH(high) cells could be propagated in vivo by serial passaging of the human tissue as xenografts and in vitro as suspension cultures called sphere cultures. In this unit, all the above-mentioned methods to isolate and propagate colon cancer stem cells using ALDH as a stem cell marker are described in detail.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914954      PMCID: PMC3975159          DOI: 10.1007/978-1-61779-980-8_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Tumor-initiating cells are rare in many human tumors.

Authors:  Kota Ishizawa; Zeshaan A Rasheed; Robert Karisch; Qiuju Wang; Jeanne Kowalski; Erica Susky; Keira Pereira; Christina Karamboulas; Nadeem Moghal; N V Rajeshkumar; Manuel Hidalgo; Ming Tsao; Laurie Ailles; Thomas K Waddell; Anirban Maitra; Benjamin G Neel; William Matsui
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

2.  Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.

Authors:  Joseph E Carpentino; Mark J Hynes; Henry D Appelman; Tong Zheng; Dennis A Steindler; Edward W Scott; Emina H Huang
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

3.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

4.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

  4 in total
  22 in total

Review 1.  Biomarkers and signaling pathways of colorectal cancer stem cells.

Authors:  Danysh Abetov; Zhanar Mustapova; Timur Saliev; Denis Bulanin
Journal:  Tumour Biol       Date:  2015-02-14

2.  Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.

Authors:  Matthew R Carstens; Robert C Fisher; Abhinav P Acharya; Elizabeth A Butterworth; Edward Scott; Emina H Huang; Benjamin G Keselowsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

3.  Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.

Authors:  Fei Liao; Jing Zhang; Yangyang Hu; Alireza Hassani Najafabadi; James J Moon; Max S Wicha; Bashir Kaspo; Joel Whitfield; Alfred E Chang; Qiao Li
Journal:  Cancer Immunol Immunother       Date:  2022-01-31       Impact factor: 6.630

4.  CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.

Authors:  Phuong T Huynh; Ellen J Beswick; Yun A Coronado; Paul Johnson; Malaney R O'Connell; Tammara Watts; Pomila Singh; Suimin Qiu; Katherine Morris; Don W Powell; Irina V Pinchuk
Journal:  Int J Cancer       Date:  2015-12-10       Impact factor: 7.396

5.  Hydrodynamic shear-based purification of cancer cells with enhanced tumorigenic potential.

Authors:  Efraín A Cermeño; Meghan J O'Melia; Woojin M Han; Austin Veith; Graham Barber; Emina H Huang; Susan N Thomas; Andrés J García
Journal:  Integr Biol (Camb)       Date:  2020-02-22       Impact factor: 2.192

6.  HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.

Authors:  Leiming Xia; Lu Wen; You Qin; Hannah E Dobson; Tao Zhang; Frank I Comer; Mary Jane Hinrichs; Michael D Oberst; Steven R Coats; Alfred E Chang; Yuanyuan Liu; Yangyi Bao; Fu Dai; Max S Wicha; Qiao Li
Journal:  Cell Chem Biol       Date:  2021-03-11       Impact factor: 8.116

7.  Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt/β-catenin pathway.

Authors:  Tao Zhang; Ke Wang; Junshu Zhang; Xiaolei Wang; Zhigang Chen; Chao Ni; Fuming Qiu; Jian Huang
Journal:  Oncol Lett       Date:  2013-01-21       Impact factor: 2.967

Review 8.  Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review).

Authors:  Yong-Ju Gao; Bo Li; Xin-Yu Wu; Jing Cui; Jian-Kui Han
Journal:  Oncol Rep       Date:  2014-01-14       Impact factor: 3.906

9.  Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.

Authors:  Li Du; Yi-Jia Li; Marwan Fakih; Rebecca L Wiatrek; Marjun Duldulao; Zhenbin Chen; Peiguo Chu; Julio Garcia-Aguilar; Yuan Chen
Journal:  Nat Commun       Date:  2016-07-28       Impact factor: 14.919

10.  Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability.

Authors:  Jennifer M J Jongen; Lizet M van der Waals; Kari Trumpi; Jamila Laoukili; Niek A Peters; Susanne J Schenning-van Schelven; Klaas M Govaert; Inne H M Borel Rinkes; Onno Kranenburg
Journal:  Oncotarget       Date:  2017-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.